Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Preparation method of chiral sertraline hydrochloride

A technology of sertraline hydrochloride and sertraline hydrochloride, which is applied in the field of preparation of chiral sertraline hydrochloride, can solve the problems of low yield, unsafe use, low production efficiency, etc., achieve high yield, simple operation process, The effect of high purity

Active Publication Date: 2019-04-16
SHANGYU JINGXIN PHARMA +1
View PDF7 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0007] The technical problem solved by the present invention is to overcome the low production efficiency caused by solvent switching in the existing chiral sertraline hydrochloride resolution method, when free, sertraline racemization, D-mandelic acid recovery process is loaded down with trivial details and yield is low ( About 70%), high cost and storage, unsafe use when salifying with hydrogen chloride alcohol solution, there are defects such as low yield again in salifying with hydrochloric acid, a kind of preparation method of chiral sertraline hydrochloride is provided

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation method of chiral sertraline hydrochloride

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0047] (1) 60 g of racemic cis-sertraline hydrochloride (the content of cis-(1S, 4S)-sertraline hydrochloride is 47%), 30.49 g of D-mandelic acid sodium salt, 130 g of n-butanol and 1.3 g of water g was added to a 500ml three-necked flask and reacted at 60°C for 3 hours, then heated up to distill off water, then heated to 118°C, filtered while hot to remove inorganic matter (mainly sodium chloride), rinsed with 10g of n-butanol, and combined to obtain filtrate 1 ;

[0048] (2) After the filtrate 1 was heated and completely dissolved, the temperature was lowered to 36.5° C., crystallized, centrifugally filtered, rinsed with 10 g of n-butanol to obtain the crude product of D-sertraline mandelate, and the combined liquids were obtained to obtain the filtrate 2;

[0049] (3) Mix the crude product of D-sertraline mandelate with 145g of n-butanol, heat up and dissolve completely, then cool down to 10°C, crystallize, centrifugally filter, rinse with 10g of n-butanol, and dry to obtai...

Embodiment 2

[0055] The preparation method of chiral sertraline hydrochloride is basically the same as in Example 1, except that the temperature in step (2) is lowered to 41°C.

[0056] Step (3), obtain 33.96g refined D-sertraline mandelic dry product;

[0057] In step (5), 23.18 g of cis-(1S,4S)-sertraline hydrochloride was obtained. The molar yield is 82.19%.

[0058] After testing, the purity of cis-(1S,4S)-sertraline hydrochloride was 99.51%, and the content was 99.87%.

[0059] In addition, 29.86 g of D-mandelic acid sodium salt was recovered according to the same method as in Example 1, and the molar recovery rate was 97.94%.

Embodiment 3

[0061] The preparation method of chiral sertraline hydrochloride is basically the same as in Example 1, except that the temperature in step (2) is lowered to 45°C.

[0062] Step (3), obtain 33.97g refined D-sertraline mandelic dry product;

[0063] In step (5), 23.15 g of cis-(1S,4S)-sertraline hydrochloride was obtained. The molar yield is 82.09%.

[0064] After testing, the purity of cis-(1S,4S)-sertraline hydrochloride was 99.49%, and the content was 99.61%.

[0065] In addition, 29.85 g of D-mandelic acid sodium salt was recovered according to the same method as in Example 1, and the molar recovery rate was 97.91%.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a preparation method of chiral sertraline hydrochloride. The method comprises the steps that cis-sertraline hydrochloride and alkali of alkali metal salt containing D-mandelicacid are mixed and stirred in a solvent, after dehydration, inorganic salt is filtered out, a filtrate is cooled and crystallized, and solid-liquid separation is carried out; coarse D-mandelic acidsertraline is recrystallized, and solid-liquid separation is carried out; refined D-mandelic acid sertraline reacts with inorganic alkali in a mixed solvent of water and the organic solvent, and dehydration, crystallization and solid-liquid separation are carried out; a filtrate and hydrogen chloride are mixed and stirred in an organic solvent, after salification is completed, solid-liquid separation, washing and drying are carried to obtain the chiral sertraline hydrochloride. The preparation method of the chiral sertraline hydrochloride has the advantages that the alkali metal salt of the D-mandelic acid is taken as a resolving agent, the yield of cis-(1S,4S)-hydrochloride sertraline is high, the single organic solvent can be adopted in the entire process, the recovery rate of the alkalimetal salt of the D-mandelic acid and solvent is high, the alkali metal salt and the solvent can be recycled, and the preparation method is simple in operation, safe, environmentally friendly and suitable for industrial production.

Description

technical field [0001] The invention relates to the field of pharmaceutical synthesis, in particular to a preparation method of chiral sertraline hydrochloride. Background technique [0002] Sertraline, CAS number: 79617-96-2, chemical name (1S,4S)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro- N-methyl-1-naphthylamine is a selective serotonin reuptake inhibitor (SSRI). The structural formulas of sertraline and its isomers are shown below: [0003] [0004] Among them, the racemate formed by 1S-cis-sertraline and 1R-cis-sertraline is cis-(±)-sertraline (or racemic cis-sertraline); 1S-trans-sertraline The racemate formed by traline and 1R-trans-sertraline is trans-(±)-sertraline (or racemic trans-sertraline). [0005] Sertraline hydrochloride is the hydrochloride salt of sertraline, with a CAS number of 79559-97-0. It is an antipsychotic depressant developed by Pfizer in the early 1990s. It has been listed in 96 countries and regions in the world so far. At present, it sti...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07C211/42C07C209/88
CPCC07B2200/07C07C51/412C07C211/42C07C2602/10C07C209/88C07C59/50
Inventor 汪平中范锦敏顾晋文蒋伟吴然
Owner SHANGYU JINGXIN PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com